Review
doi: 10.1016/j.jacc.2007.10.028.
Off-label use of drug-eluting stents putting it in perspective
- PMID: 18261679
- DOI: 10.1016/j.jacc.2007.10.028
Item in Clipboard
Review
Off-label use of drug-eluting stents putting it in perspective
J Am Coll Cardiol.
.
Free article
No abstract available
Comment on
-
"Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents.J Am Coll Cardiol. 2008 Feb 12;51(6):607-14. doi: 10.1016/j.jacc.2007.08.064. J Am Coll Cardiol. 2008. PMID: 18261678 Clinical Trial.
Similar articles
-
Debating the risks of drug-eluting stents.N Engl J Med. 2007 Jan 25;356(4):325-8. doi: 10.1056/NEJMp068300. N Engl J Med. 2007. PMID: 17251527 No abstract available.
-
Three years since the FDA advisory panel on drug-eluting stents: what have we learned about off-label use and stent thrombosis?J Invasive Cardiol. 2010 Jan;22(1):20-1. J Invasive Cardiol. 2010. PMID: 20048394 No abstract available.
-
Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.Circ Cardiovasc Interv. 2008 Dec;1(3):217-25. doi: 10.1161/CIRCINTERVENTIONS.108.811380. Circ Cardiovasc Interv. 2008. PMID: 20031681 No abstract available.
-
The safety of drug-eluting stents.Ther Adv Cardiovasc Dis. 2008 Feb;2(1):43-52. doi: 10.1177/1753944707088158. Ther Adv Cardiovasc Dis. 2008. PMID: 19124407 Review.
-
Coronary stents: current status.J Am Coll Cardiol. 2010 Aug 31;56(10 Suppl):S1-42. doi: 10.1016/j.jacc.2010.06.007. J Am Coll Cardiol. 2010. PMID: 20797502 Review.
Cited by
-
Off-Label Use vs Off-Label Marketing: Part 2: Off-Label Marketing-Consequences for Patients, Clinicians, and Researchers.JACC Basic Transl Sci. 2023 Mar 27;8(3):359-370. doi: 10.1016/j.jacbts.2022.12.012. eCollection 2023 Mar. JACC Basic Transl Sci. 2023. PMID: 37034284 Free PMC article.
-
Comparison between on-label versus off-label use of drug-eluting coronary stents in clinical practice: results from the German DES.DE-Registry.Clin Res Cardiol. 2011 Aug;100(8):701-9. doi: 10.1007/s00392-011-0301-8. Epub 2011 Mar 18. Clin Res Cardiol. 2011. PMID: 21416192
-
Comparison between treatment of "established" versus complex "off-label" coronary lesions with Absorb® bioresorbable scaffold implantation: results from the GABI-R® registry.Clin Res Cardiol. 2020 Mar;109(3):374-384. doi: 10.1007/s00392-019-01517-8. Epub 2019 Jun 29. Clin Res Cardiol. 2020. PMID: 31256259
-
Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use-Patient Harms and Prescriber Responsibilities.JACC Basic Transl Sci. 2023 Feb 27;8(2):224-233. doi: 10.1016/j.jacbts.2022.12.011. eCollection 2023 Feb. JACC Basic Transl Sci. 2023. PMID: 36908673 Free PMC article.
-
Increased artery wall stress post-stenting leads to greater intimal thickening.Lab Invest. 2011 Jun;91(6):955-67. doi: 10.1038/labinvest.2011.57. Epub 2011 Mar 28. Lab Invest. 2011. PMID: 21445059 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
